Exhibiting at FOOD INGREDIENTS CHINA 2025

Nu-Mega Ingredients Pty Ltd is a pioneering Australian manufacturer and global supplier of highly functional nutritional oils and microencapsulated omega-3 and omega-6 powders, headquartered in Altona North, Victoria. As a part of the larger Clover Corporation Limited group, Nu-Mega plays a central role in delivering tailored lipid-based ingredients for infant nutrition, clinical nutrition, and functional foods worldwide.

Core Business and Product Offerings

Nu-Mega Ingredients specializes in the development and production of advanced nutritional lipids derived primarily from tuna oil and algal oil, known for their high DHA (Docosahexaenoic Acid) content. The company has developed proprietary encapsulation technologies to deliver omega-rich ingredients in a stable and bioavailable format.

Key Product Lines

• Microencapsulated Omega-3 Powders

  • Derived from marine (tuna) oil or algae
  • High in DHA content
  • Designed for stability, taste masking, and shelf life in infant formulas and powdered nutrition products

• Microencapsulated Omega-6 Powders

  • Rich in ARA (Arachidonic Acid)
  • Complementary to omega-3 products for balanced infant and early-life nutrition

• Nutritional Oils

  • DHA-rich tuna oil
  • Algal DHA oil
  • ARA-rich fungal oil

• Emulsions and Specialty Lipids

  • Used in clinical and sports nutrition, beverages, and bakery applications

Proprietary Brands

• Driphorm®

  • Advanced microencapsulation system offering excellent powder flow and reconstitution performance

• Gelphorm®

  • Patented gelatin-based delivery matrix ideal for softgel and encapsulated formats

• HiDHA®

  • High DHA concentration omega-3 ingredient optimized for infant formula and medical nutrition applications

Specialization and USP

Nu-Mega’s unique selling proposition lies in its ability to deliver:

• High-purity, high-bioavailability DHA and ARA ingredients
• Microencapsulation technologies that protect oils from oxidation, ensuring extended shelf life and minimal taste impact
• Regulatory expertise in meeting infant formula and medical food standards globally
• Custom formulations to match client-specific nutritional and performance profiles

As a division of Clover Corporation, Nu-Mega benefits from ongoing R&D investments and access to patented technologies that enhance ingredient performance across diverse applications.

Target Markets

Nu-Mega Ingredients serves customers across:

• Infant Formula Manufacturers
• Clinical and Medical Nutrition Providers
• Functional Food and Beverage Producers
• Dietary Supplement Brands

Key export markets include:

• China
• Southeast Asia
• Europe
• United States
• Latin America

The company maintains a strong presence in regulatory-sensitive markets where clean-label and clinically proven lipid nutrition is in high demand.

Capabilities and Technical Infrastructure

Nu-Mega operates GMP-certified manufacturing facilities in Australia and partners with formulation and application labs worldwide. Key infrastructure includes:

• High-efficiency spray drying and microencapsulation systems
• Cold-chain oil refining and purification lines
• On-site QA/QC laboratories
• Specialized R&D team focused on lipid stability, sensory optimization, and regulatory compliance

Its facilities meet infant nutrition-grade hygiene and formulation standards.

Certifications and Compliance

Nu-Mega’s ingredients are manufactured under strict global food safety and regulatory frameworks, including:

• GMP Certification
• ISO 9001 Quality Management
• HACCP
• Kosher and Halal Certifications
• China’s SAMR infant formula registration
• GRAS status for relevant DHA and ARA ingredients in the U.S.
• European Union Novel Food Compliance

The company provides full documentation support including nutritional specs, MSDS, COA, and shelf-life data.

Financial and Shipment Insights

As part of Clover Corporation Ltd (ASX: CLV), Nu-Mega contributes to a publicly listed business with strong financials. According to Clover Corporation’s FY2023 Annual Report:

• Revenue exceeded AUD 95 million
• Nu-Mega's DHA product lines were responsible for the majority of group earnings
• Export sales accounted for over 85% of total revenue, underscoring Nu-Mega’s strong global footprint

Trade data confirms ongoing shipments of Driphorm® DHA powders to infant nutrition companies in China, Vietnam, South Korea, and Germany, with monthly volumes ranging between 5 and 20 metric tons.

Major Achievements

• Introduced HiDHA® tuna oil, one of the first high-DHA oils tailored for infant formula
• Played a key role in supporting DHA inclusion in Chinese and Southeast Asian regulatory frameworks for infant products
• Expanded encapsulated omega-3 solutions into adult clinical nutrition and sports recovery markets
• Achieved near-global presence through regulatory approvals in over 25 countries
• Contributed to clinical studies on the neurological and visual development benefits of early-life DHA supplementation

Nu-Mega Ingredients Pty Ltd continues to set global benchmarks for the stability, efficacy, and regulatory reliability of lipid-based nutritional ingredients, driving innovation in maternal, infant, and therapeutic nutrition across five continents.